Related Experiment Video
Updated: Jul 18, 2026
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
MUC16: clinical targets with great potential.
Xin-Yu Zhang1,2,3, Lian-Lian Hong1,2, Zhi-Qiang Ling4,5,6
1Zhejiang Cancer Institute, Zhejiang Cancer Hospital, No.1 Banshan East Rd., Gongshu District, Hangzhou, 310022, Zhejiang, China.
Clinical and Experimental Medicine
|May 17, 2024
Summary
Mucin 16 (MUC16) is a key protein in cancer development and immune evasion. Targeting MUC16 offers a promising new avenue for cancer therapy and treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Mucin 16 (MUC16) is aberrantly expressed in various cancers, unlike its presence in normal epithelium.
- MUC16 and its extracellular domains serve as critical cancer biomarkers.
- Abnormal MUC16 expression is implicated in tumor progression and development.
Purpose of the Study:
- To detail the mechanisms by which MUC16 influences cancer development.
- To elucidate MUC16's role in tumor immune escape.
- To highlight MUC16's potential as a therapeutic target.
Main Methods:
- Review of literature on MUC16's role in cancer.
- Analysis of MUC16's involvement in signaling pathways (e.g., PI3K/AKT, JAK2/STAT3).
- Examination of MUC16's impact on immune cells like T cells and NK cells.
Main Results:
- MUC16 promotes tumor progression via pathways including mesenchymal protein, PI3K/AKT, JAK2/STAT3, and ERK/FBW7/c-Myc.
- MUC16 contributes to tumor immune escape by inhibiting T cell and NK cell activity.
- Numerous drugs and clinical trials targeting MUC16 are under development.
Conclusions:
- MUC16 plays a significant role in cancer occurrence, progression, and immune evasion.
- MUC16 represents a potential new direction for cancer treatment strategies.
- Further research into MUC16 mechanisms supports its clinical therapeutic potential.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...